NC
GILD icon

Nexthera Capital’s Gilead Sciences GILD Stock Holding History

Nexthera Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$1.26M Buy
+18,697
New +$1.23M 1.05% 21

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Nexthera Capital's GILD Position: Q2 2019 in Review

Nexthera Capital opened a new position in Gilead Sciences (GILD) in Q2 2019: 18,697 shares worth $1.26M. The stake represents 1.05% of the portfolio and ranks #21 among its holdings.

1,483 funds tracked by Wall St. Rank hold GILD as of Q2 2019.

  • Nexthera Capital held 18,697 shares of Gilead Sciences worth $1.26M as of Q2 2019.
  • Gilead Sciences was a new Nexthera Capital position in Q2 2019.
  • Gilead Sciences made up 1.05% of Nexthera Capital's portfolio in Q2 2019, its #21 holding.
  • 1,483 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2019.

Based on Nexthera Capital's 13F filing for Q2 2019, filed 14 Aug 2019.